EN PT


1162/2010 - Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance
Análise de Custo-efetividade do rastreamento do câncer de mama com mamografia convencional, digital e ressonância.

Author:

• Antonio Augusto de Freitas Peregrino - Peregrino, AAF - Rio de Janeiro, Rio de Janeiro - Universidade do Estado do Rio de Janeiro - <antoniop@uerj.br>

Co-author(s):

• Carlos Eduardo Veloso de Almeida - de Almeida, CEV - Laboratório de Ciências Radiológicas - UERJ - <cea71@yahoo.com>
• Cid Manso de Mello Vianna - Vianna, CM - Instituto de Medicina Social - <cdvianna@gmail.com>
• Frances Valeria Costa e Silva - Costa e Silva. FV - Universidade do Estado do Rio de Janeiro - <francesvcs@gmail.com>
• Gabriela Bittencourt Gonzalez Mosegui - Mosegui, GBG - Departamento de Saúde e Sociedade - UFF - <gabrielamosegui@uol.com.br>
• Marcus Paulo da Silva Rodrigues - Rodrigues, MPS - Universidade do Estado do Rio de Janeiro - <mps_rodrigues@yahoo.com.br>
• Samara Cristina Ferreira Machado - Ferreira-Machado, SC - Instituto de Biologia - UFF - <samararossatti@gmail.com>

Thematic Area:

Políticas em Saúde

Abstract:

A cost-effectiveness analysis was conducted in screening for breast cancer. The use of conventional mammography, digital and magnetic resonance imaging were compared with natural disease history as baseline. A Markov model projected breast cancer in a group of 100,000 women for a 30 year period, with screening every two years. Four distinct scenarios were modeled: (1) the natural history of breast cancer, as a baseline, (2) conventional film mammography, (3) digital mammography and (4) magnetic resonance imaging. The costs of the scenarios modeled ranged from R$ 194.216,68 for natural history, up to R$ 48.614.338,31, for screening with magnetic resonance imaging. The difference in effectiveness between the interventions ranged from 300 to 78.000 years of life gained in the cohort. The ratio of incremental cost-effectiveness in terms of cost per life-year gains, conventional mammographic screening has produced an extra year for R$ 13.573,07. The ICER of magnetic resonance imaging was R$ 2.904.328,88, compared to no screening. In conclusion, it is more cost-effective to perform the screening with conventional mammography than other technological interventions.

Keywords:

cost-effectiveness Markov model mammography breast cancer

Content:

Access Issue in Scielo

Other languages:







How to

Cite

Peregrino, AAF, de Almeida, CEV, Vianna, CM, Costa e Silva. FV, Mosegui, GBG, Rodrigues, MPS, Ferreira-Machado, SC. Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance. Cien Saude Colet [periódico na internet] (2011/Mar). [Citado em 21/01/2025]. Está disponível em: http://cienciaesaudecoletiva.com.br/en/articles/costeffectiveness-of-screening-for-breast-cancer-with-conventional-mammography-digital-and-magnetic-resonance/6864?id=6864



Execution



Sponsors